![ShareCast](https://static.lse.co.uk/images/news-logos/sharecast-news-logo.png)
Futura enters erection gel licensing deal with M8
(Sharecast News) - Futura Medical has entered into a licensing agreement with M8 Pharmaceuticals, a specialty biopharmaceutical company focused on commercialisation in Latin America, for the rights to exclusively develop and commercialise its topical, gel-based erectile dysfunction (ED) treatment MED3000 in Brazil and Mexico, it announced on Tuesday.
Read more